Sera Prognostics’ PreTRM® Test Wins 2016 Utah Innovation Award in Life Sciences
May 12, 2016 14:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, May 12, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s health company, today announced that it was selected as the 2016 Utah Innovation Award winner in the Life Science –...
Landmark Study Published in American Journal of Obstetrics & Gynecology Validates New Blood Test as Objective, Predictive Tool for Preterm Birth Risk
March 10, 2016 07:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, March 10, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that clinical validation data from the 5,501 patient Proteomic Assessment of...
Sera Prognostics to Present at 34th Annual J.P. Morgan Healthcare Conference
December 21, 2015 12:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Dec. 21, 2015 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, todayannounced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer,...
Sera Prognostics to Present at 27th Annual Piper Jaffray Healthcare Conference
November 24, 2015 12:24 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Nov. 24, 2015 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer,...
Sera Prognostics Appoints Investor Arnold L. Oronsky, Ph.D., to Board of Directors
February 24, 2015 09:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Feb. 24, 2015 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's healthcare company, today announced that Arnold L. Oronsky, Ph.D., General Partner at InterWest Partners, LLC, was...
Sera Prognostics Closes $20 Million in Series B Financing
January 07, 2015 09:00 ET
|
Sera Prognostics, Inc.
SALT LAKE CITY, Jan. 7, 2015 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's healthcare company, today announced that it has closed $20 Million in Series B financing. Leading the Series B...